TITLE

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

AUTHOR(S)
Yih, W. Katherine; Brooks, Daniel R.; Lett, Susan M.; Jumaan, Aisha O.; Zi Zhang; Clements, Karen M.; Seward, Jane F.
PUB. DATE
January 2005
SOURCE
BMC Public Health;2005, Vol. 5, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The authors sought to monitor the impact of widespread varicella vaccination on the epidemiology of varicella and herpes zoster. While varicella incidence would be expected to decrease, mathematical models predict an initial increase in herpes zoster incidence if re-exposure to varicella protects against reactivation of the varicella zoster virus. Methods: In 1998-2003, as varicella vaccine uptake increased, incidence of varicella and herpes zoster in Massachusetts was monitored using the random-digit-dial Behavioral Risk Factor Surveillance System. Results: Between 1998 and 2003, varicella incidence declined from 16.5/1,000 to 3.5/1,000 (79%) overall with =66% decreases for all age groups except adults (27% decrease). Age-standardized estimates of overall herpes zoster occurrence increased from 2.77/1,000 to 5.25/1,000 (90%) in the period 1999-2003, and the trend in both crude and adjusted rates was highly significant (p < 0.001). Annual age-specific rates were somewhat unstable, but all increased, and the trend was significant for the 25-44 year and 65+ year age groups. Conclusion: As varicella vaccine coverage in children increased, the incidence of varicella decreased and the occurrence of herpes zoster increased. If the observed increase in herpes zoster incidence is real, widespread vaccination of children is only one of several possible explanations. Further studies are needed to understand secular trends in herpes zoster before and after use of varicella vaccine in the United States and other countries.
ACCESSION #
29361830

 

Related Articles

  • Chickenpox vaccination should be introduced, study concludes.  // Practice Nurse;11/23/2007, Vol. 34 Issue 9, p8 

    The article reports that a study in the "Archives of Disease in Childhood" recommended the introduction of chickenpox vaccines in Great Britain and Ireland. The researchers noted that vaccinating children is the only way to prevent illness and death from chickenpox. They found that chickenpox...

  • Review: vaccines prevent influenza and influenza-like illness in healthy children >2 years of age. Smith, S.; Demicheli, V.; Di Pietrantonj, C. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p140 

    The article presents a study conducted in Great Britain which showed that vaccines are effective for the prevention of influenza and influenza-like illness for healthy children over two years of age. One factor considered in the study is the adverse effects of the vaccines in children with ages...

  • More MMR debate. Nicholson, Marian // Practice Nursing;Dec2007, Vol. 18 Issue 12, p588 

    The article presents comments of the author on the proposal of combining Oka vaccine against chickenpox with measles, mumps and rubella (MMR) to create a new vaccine including varicella (MMRV). The author informs that cynics say that the main reason for proposing MMRV by manufacturers is that...

  • SCRATCH NO MORE. Raymond, Joan // Newsweek;9/20/2004, Vol. 144 Issue 12, p58 

    Discusses the use of the varicella vaccine for children to avoid the chickenpox. Success of the vaccine in reducing hospitalization of children for chickenpox; Debate about whether the timing of the vaccine is correct.

  • Another injection? Moore, Alison // Nursing Standard;1/9/2008, Vol. 22 Issue 18, p23 

    The article provides information on the efficacy of vaccination to protect children from chickenpox in Great Britain. This vaccination can reduce the number of cases by over 80% has been widely used in the U.S. and Germany. Some healthcare professionals would support vaccination but are...

  • Sixteen Years of Global Experience with the First Refrigerator-Stable Varicella Vaccine (Varilrixâ„¢). Kreth, Hans W.; Bee-Wah Lee; Kosuwon, Pensri; Salazar, Jose; Gloriani-Barzaga, Nina; Bock, Hans L.; François Meurice // BioDrugs;2008, Vol. 22 Issue 6, p387 

    Without vaccination, chickenpox (varicella) will affect almost every person in the world during their lifetime. The burden of disease due to varicella is often unrecognized. Varilrixâ„¢ is a varicella vaccine derived from the Oka strain of varicella virus. The vaccine, as a frozen...

  • PCV7 may have reduced pneumococcal infections among White Mountain Apache population. Volansky, Rob // Infectious Diseases in Children;Sep2008, Vol. 21 Issue 9, p26 

    The article discusses research being done on pneumococcal infections. It references a study by R. Lacapa et al, published in a 2008 issue of "Clinical Infectious Diseases." Study findings revealed that the incidence of pneumococcal infections among White Mountain Apache children has declined...

  • Parental opinions on childhood varicella and the varicella vaccine: a UK multicentre qualitative interview study. Lee, Emily; Turner, Jennifer; Bate, Jessica // Archives of Disease in Childhood;Sep2011, Vol. 96 Issue 9, p901 

    The article discusses the result of a study which aims to explore parental experiences and perceptions of childhood varicella and to gain attitudes towards the universal varicella vaccination programme in Great Britain. It shows that the parents surveyed were unaware of the existence of an...

  • Insights into Long-Lasting Protection Induced by RTS,S/ AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children. Guinovart, Caterina; Aponte, John J.; Sacarlal, Jahit; Aide, Pedro; Leach, Amanda; Bassat, Quique; Macete, Eusébio; Dobaño, Carlota; Lievens, Marc; Loucq, Christian; Ballou, W. Ripley; Cohen, Joe; Alonso, Pedro L. // PLoS ONE;2009, Vol. 4 Issue 4, p1 

    Background: The pre-erythrocytic malaria vaccine RTS,S/AS02A has shown to confer protection against clinical malaria for at least 21 months in a trial in Mozambican children. Efficacy varied between different endpoints, such as parasitaemia or clinical malaria; however the underlying mechanisms...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics